Remove Development Remove In-Vitro Remove Life Science Remove Radiology
article thumbnail

Meeting public expectations of diagnostics is the next big test for the NHS

pharmaphorum

Diagnostics was never a Cinderella sector; Britain has the fifth largest in vitro diagnostics (IVD) market in Europe, not gigantic but significant nevertheless. Across the UK, radiology departments are understaffed by around 43%, while only 3% of histopathology departments have enough staff to meet clinical demand.

article thumbnail

The Utility of Liquid Biopsy in Oncology Clinical Trials

XTalks

Liquid biopsies have demonstrated promising activity in multiple clinical settings, but the great enthusiasm and expectations around them can be harmful if not adequately managed,” said Dr. El Mustapha Bahassi, PhD, Director, Clinical Laboratory Sciences, at the global clinical research organization (CRO) Medpace.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Considerations for Mobile Health Technology Developers: Part 2

pharmaphorum

On 27th September 2022, the Food and Drug Administration (FDA) issued its final guidance for industry and FDA staff clinical decision support (CDS) software, which has been anticipated since the Center for Devices and Radiological Health (CDRH) listed the guidance as a top priority for fiscal year 2022. Criterion 1. Criterion 2.

article thumbnail

Healthy.io’s Smartphone-Powered Minuteful Kidney Test Gets FDA Clearance

XTalks

Around one in three adults in the US (or about 80 million Americans) are at risk of developing CKD. The Minuteful Kidney test kit is delivered to the patient’s home and is made up of all these things needed for in vitro home ACR testing: A urine collection cup. Healthy.io An early diagnosis would help avoid end-stage kidney disease.

Reagent 98
article thumbnail

Top 10 Medical Device Companies in 2023 by Revenue Statistics and Trends

XTalks

These powerhouse organizations have not only distinguished themselves through their cutting-edge devices and technologies but also via their robust research and development (R&D) capabilities, unwavering commitment to quality and extensive global reach. 1) Medtronic 2022 Revenue: Medtronic reported an annual revenue of $31.69

article thumbnail

New HCV Test Enables Diagnosis and Treatment in a Single Visit

XTalks

” The Xpert HCV test’s development was validated through the Independent Test Assessment Program (ITAP), part of the National Institutes of Health’s (NIH) Rapid Acceleration of Diagnostics (RADx) Tech program. The infection, if left untreated, can lead to severe health issues such as liver cancer and liver failure.

RNA 96
article thumbnail

COVID-19 Pandemic Coverage

XTalks

And in truth, the companies the White House picked were pretty savvy as several are current front-runners in the race to develop a vaccine. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. Moderna’s COVID-19 Vaccine.